IL17A and demyelinating disease: Furthermore, Baxi’s study demonstrated that both Th1 and Th17 cells infiltrated into the CNS of mice with demyelinating disease, which inhibited endogenous remyelination in the CNS by secreting IFN-γ and interleukin 17 (IL-17) (38).